Who owns the TERLIVAZ TERLIPRESSIN FOR INJECTION trademark?

The TERLIVAZ TERLIPRESSIN FOR INJECTION trademark is owned by MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED.

What class is the TERLIVAZ TERLIPRESSIN FOR INJECTION trademark registered in?

The TERLIVAZ TERLIPRESSIN FOR INJECTION trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for TERLIVAZ TERLIPRESSIN FOR INJECTION?

The USPTO serial number for TERLIVAZ TERLIPRESSIN FOR INJECTION is 88900093.

What is the registration number for TERLIVAZ TERLIPRESSIN FOR INJECTION?

TERLIVAZ TERLIPRESSIN FOR INJECTION is registered under USPTO registration number 7081079.

TER

USPTO Trademark Record

REGISTERED

TERLIVAZ TERLIPRESSIN FOR INJECTION

SN 88900093·Reg 7081079·Filed May 04, 2020

Owner MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

TERLIVAZ TERLIPRESSIN FOR INJECTION (Serial No. 88900093), Registration No. 7081079, is a registered US trademark filed on May 04, 2020 by MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: June 13, 2029

Mark Intelligence

TERLIVAZ TERLIPRESSIN FOR INJECTION (Reg. #7081079) is a registered US trademark that has been protecting its owner, MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 04, 2020

SERIAL

88900093

REG#

7081079

REGISTERED

Jun 13, 2023

Owner

Applicant

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED

Entity

Limited (UK / Scandinavian)

Address

College Business & Technology Park, Cruiserath Road, Blanchardstown, Dublin 15, D15TX2V

Country

Attorney

NameCamille M. Miller

Law firm

Camille M. Miller Cozen O'Connor

Address

1650 Market Street, Suite 2800, Philadelphia, PA 19103, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 04, 2020

Serial Number88900093

Registration No.7081079

Registration DateJun 13, 2023

Status DateJun 13, 2023

Published for OppositionSep 08, 2020

Mark TypeDesign with words

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 12, 2022

First use in commerce: Oct 12, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

41 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Mar 13, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Mar 13, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 13, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 13, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Mar 13, 2026

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 13, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jun 13, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 13, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 09, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 07, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Mar 21, 2023

STATEMENT OF USE PROCESSING COMPLETE

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jan 04, 2023

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Dec 28, 2022

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 21, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Nov 01, 2022

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Nov 01, 2022

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 06, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 04, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Apr 04, 2022

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Apr 04, 2022

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 08, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 06, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Oct 06, 2021

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Oct 06, 2021

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 21, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 19, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Apr 19, 2021

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Apr 19, 2021

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 03, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 08, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 08, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 19, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Aug 05, 2020

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Aug 05, 2020

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 05, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Aug 05, 2020

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 05, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jul 29, 2020

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 16, 2020

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 15, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 07, 2020

NEW APPLICATION ENTERED

TERLIVAZ TERLIPRESSIN FOR INJECTION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Camille M. Miller

Resources

Company